Literature DB >> 31499210

Efficacy of ventriculoperitoneal shunting in patients with cryptococcal meningitis with intracranial hypertension.

Ying Liu1, Xiaohua Peng2, Weizhen Weng3, Jianyun Zhu4, Hong Cao5, Shibin Xie6.   

Abstract

BACKGROUND: Ventriculoperitoneal (VP) shunting in cryptococcal meningitis (CM) patients with high intracranial pressure (ICP) has been studied extensively.
METHODS: A total of 74 CM patients with ICP were identified, including 27 patients with or without ventriculomegaly receiving VP shunting.
RESULTS: Through retrospective analysis, there was an obvious decline in ICP as well as Cryptococcus count after VP shunting. Damage to the cranial nerves was improved after the surgery. For those patients receiving VP shunting, there was an obvious decline in ICP as well as Cryptococcus count, with less usage of mannitol. Hydrocephalus or ventriculomegaly was improved, and both the clearance time of Cryptococcus and the hospitalization time were shortened (p<0.05). The complications of VP shunting were not common.
CONCLUSIONS: For patients diagnosed with CM and with apparent ICP, VP shunting can be considered regardless of whether there is damage to the cranial nerves or hydrocephaly.
Copyright © 2019 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Cryptococcal meningitis; Cryptococcus count; Intracranial pressure; Ventriculomegaly; Ventriculoperitoneal shunting

Mesh:

Year:  2019        PMID: 31499210     DOI: 10.1016/j.ijid.2019.08.034

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  4 in total

1.  Ventriculoperitoneal shunt is associated with increased cerebrospinal fluid protein level in HIV-infected cryptococcal meningitis patients.

Authors:  Ran Tao; Lijun Xu; Yongzheng Guo; Xiaoke Xu; Jiesheng Zheng; Biao Zhu
Journal:  BMC Infect Dis       Date:  2022-03-26       Impact factor: 3.090

2.  Clinical features and risk factors of surgical site infections in HIV-negative patients with cryptococcal meningitis underwent ventriculoperitoneal shunt operations: a retrospective study.

Authors:  Lejia Xu; Jianyun Zhu; Xiaoyun Wang; Guofen Zeng; Zhiliang Gao; Jing Liu
Journal:  BMC Infect Dis       Date:  2022-09-14       Impact factor: 3.667

3.  Amphotericin B plus fluorocytosine combined with voriconazole for the treatment of non-HIV and non-transplant-associated cryptococcal meningitis: a retrospective study.

Authors:  Junyu Liu; Jia Liu; Xiaohong Su; Lu Yang; Yijie Wang; Anni Wang; Xiaofeng Xu; Min Li; Ying Jiang; Fuhua Peng
Journal:  BMC Neurol       Date:  2022-07-22       Impact factor: 2.903

4.  Therapeutic Lumbar Punctures in Human Immunodeficiency Virus-Associated Cryptococcal Meningitis: Should Opening Pressure Direct Management?

Authors:  Enock Kagimu; Nicole Engen; Kenneth Ssebambulidde; John Kasibante; Tadeo K Kiiza; Edward Mpoza; Lillian Tugume; Edwin Nuwagira; Laura Nsangi; Darlisha A Williams; Kathy Huppler Hullsiek; David R Boulware; David B Meya; Joshua Rhein; Mahsa Abassi; Abdu K Musubire
Journal:  Open Forum Infect Dis       Date:  2022-08-17       Impact factor: 4.423

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.